Kymera Therapeutics, Inc.
At Close: 4:00 PM
Pre Market: 4:18 AM
Kymera Therapeutics, Inc.
KYMR Stock Price Today
Kymera Therapeutics, Inc. (KYMR) stock rallied over 3.86% intraday to trade at $36.85 a share on NASDAQ. The stock opened with a loss of -0.68% at $35.24 and touched an intraday high of $37.6, rising 3.86% against the last close of $35.48. The Kymera Therapeutics, Inc. in stock market went to a low of $34.68 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue$56.75 Million
5Y Sales Change-
Fiscal Year EndsDec. 2021
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Frequently Asked Questions
What is the current Kymera Therapeutics, Inc. (KYMR) stock price?
Kymera Therapeutics, Inc. (NASDAQ: KYMR) stock price is $36.85 in the last trading session. During the trading session, KYMR stock reached the peak price of $37.6 while $34.68 was the lowest point it dropped to. The percentage change in KYMR stock occurred in the recent session was 3.86% while the dollar amount for the price change in KYMR stock was $1.37.
KYMR's industry and sector of operation?
The NASDAQ listed KYMR is part of Biotechnology industry that operates in the broader Health Care sector. Kymera Therapeutics, Inc. , a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system.
Who are the executives of KYMR?
Ms. Karen Martin J.D., Ph.D.
VP & Head of Legal
Director of Corp. Communications
Dr. Bruce L. Booth D.Phil., DPHIL, Ph.D.
Co-Founder & Chairman
Dr. Nello Mainolfi M.D., Ph.D.
Co-Founder, Pres, CEO & Director
How KYMR did perform over past 52-week?
KYMR's closing price is 1.80% higher than its 52-week low of $13.15 where as its distance from 52-week high of $46.22 is -0.20%.
How many employees does KYMR have?
Number of KYMR employees currently stands at 169. KYMR operates from 200 Arsenal Yards Boulevard, Suite 230, Watertown, MA 02472, United States.
Link for KYMR official website?
Official Website of KYMR is: https://www.kymeratx.com
How do I contact KYMR?
How many shares of KYMR are traded daily?
KYMR stock volume for the day was 515,012 shares. The average number of KYMR shares traded daily for last 3 months was 777.19 Thousands.
What is the market cap of KYMR currently?
The market value of KYMR currently stands at $1.95 Billion with its latest stock price at $36.85 and 54.54 Million of its shares outstanding.